share_log

BTIG Maintains Buy on Organogenesis Hldgs, Lowers Price Target to $4

Benzinga ·  Aug 10, 2023 15:47

BTIG analyst Ryan Zimmerman maintains Organogenesis Hldgs (NASDAQ:ORGO) with a Buy and lowers the price target from $10 to $4.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment